These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29214511)

  • 1. Managing Gout Flares in the Elderly: Practical Considerations.
    Abhishek A
    Drugs Aging; 2017 Dec; 34(12):873-880. PubMed ID: 29214511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of acute and chronic gouty arthritis: present state-of-the-art.
    Schlesinger N
    Drugs; 2004; 64(21):2399-416. PubMed ID: 15481999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized, Double-Blind, Active- and Placebo-Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout.
    Poiley J; Steinberg AS; Choi YJ; Davis CS; Martin RL; McWherter CA; Boudes PF;
    Arthritis Rheumatol; 2016 Aug; 68(8):2027-34. PubMed ID: 26989892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gout management: an update].
    Ankli B; Krähenbühl S
    Ther Umsch; 2016; 73(3):115-24. PubMed ID: 27008442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New urate-lowing therapies.
    Abhishek A
    Curr Opin Rheumatol; 2018 Mar; 30(2):177-182. PubMed ID: 29251661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of gout in the older adult.
    Fravel MA; Ernst ME
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):271-85. PubMed ID: 21849262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of acute gout.
    Conway N; Schwartz S
    Med Health R I; 2009 Nov; 92(11):356-8. PubMed ID: 19999893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new perspective on the pharmacoeconomics of colchicine.
    Wertheimer AI; Davis MW; Lauterio TJ
    Curr Med Res Opin; 2011 May; 27(5):931-7. PubMed ID: 21370937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drugs and colchicine to prevent gout flare during early urate-lowering therapy: perspectives on alternative therapies and costs.
    Peterson DM
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):402-4. PubMed ID: 21133751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2020 Recommendations from the French Society of Rheumatology for the management of gout: Management of acute flares.
    Latourte A; Pascart T; Flipo RM; Chalès G; Coblentz-Baumann L; Cohen-Solal A; Ea HK; Grichy J; Letavernier E; Lioté F; Ottaviani S; Sigwalt P; Vandecandelaere G; Richette P; Bardin T
    Joint Bone Spine; 2020 Oct; 87(5):387-393. PubMed ID: 32422339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates on the treatment of gout, including a review of updated treatment guidelines and use of small molecule therapies for difficult-to-treat gout and gout flares.
    Soskind R; Abazia DT; Bridgeman MB
    Expert Opin Pharmacother; 2017 Aug; 18(11):1115-1125. PubMed ID: 28658988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing problem gout.
    Fam AG
    Ann Acad Med Singap; 1998 Jan; 27(1):93-9. PubMed ID: 9588282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of gout in older adults: barriers to optimal control.
    Hoskison KT; Wortmann RL
    Drugs Aging; 2007; 24(1):21-36. PubMed ID: 17233545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gout: nonsteroidal anti-inflammatory drugs and colchicine to prevent painful flares during early urate-lowering therapy.
    Kuritzky L; Panchal R
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):397-401. PubMed ID: 21133750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis for acute gout flares after initiation of urate-lowering therapy.
    Latourte A; Bardin T; Richette P
    Rheumatology (Oxford); 2014 Nov; 53(11):1920-6. PubMed ID: 24758886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study.
    Yamanaka H; Tamaki S; Ide Y; Kim H; Inoue K; Sugimoto M; Hidaka Y; Taniguchi A; Fujimori S; Yamamoto T
    Ann Rheum Dis; 2018 Feb; 77(2):270-276. PubMed ID: 29102957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The practical management of gout.
    Schumacher HR; Chen LX
    Cleve Clin J Med; 2008 Jul; 75 Suppl 5():S22-5. PubMed ID: 18819330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing your patient with gout: a review of treatment options.
    Doghramji PP
    Postgrad Med; 2011 May; 123(3):56-71. PubMed ID: 21566416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of management of gout: a comparison of recent guidelines.
    Khanna PP; FitzGerald J
    Curr Opin Rheumatol; 2015 Mar; 27(2):139-46. PubMed ID: 25611299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks and benefits of drugs used in the management and prevention of gout.
    Conaghan PG; Day RO
    Drug Saf; 1994 Oct; 11(4):252-8. PubMed ID: 7848545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.